Risk of lactic acidosis associated with metformin use in patients with type 2 diabetes and moderate-severe chronic kidney disease: a case-control study (ALIMAR-C2)

First published 05/07/2016

Last updated 13/12/2018

EU PAS number:

EUPAS13969

Study

Ongoing

Documents

Study protocol

Study results

Study report

Other information

ENCePP Seal

This study has been awarded the ENCePP seal

ENCePP Seal documents

Conflicts of interest of investigators

Annex 5.Declaration of interests for ENCePP SEAL studies

English (467.52 KB - PDF)View document

Composition of steering group and observers

EUPAS13969-13968

English (7.63 KB - PDF)View document

Secondary tabs